Precigen (PGEN) Revenue (2012 - 2026)
Precigen (PGEN) posted quarterly Revenue of $23.3 million for Q1 2026, up 1633.93% year-over-year from $1.3 million in Q1 2025, and up 195.6% quarter-over-quarter from $7.9 million in Q4 2025.
Precigen (PGEN) Revenue (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Revenue for 15 consecutive years, with $23.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue rose 1633.93% year-over-year to $23.3 million; the TTM figure through Mar 2026 stood at $32.8 million (up 471.25% YoY), while the FY2025 annual figure was $9.7 million, up 146.73% from the prior year.
- Revenue rose to $23.3 million in Q1 2026 per PGEN's latest filing, from $7.9 million in the prior quarter.
- Across five years, Revenue topped out at $23.3 million in Q1 2026 and bottomed at -$14.5 million in Q4 2022.
- Historically, Revenue has averaged $3.2 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2023 — Revenue tumbled 99.99% — and 2025, when it jumped 94100.0%.
- Precigen's Revenue stood at -$14.5 million in 2022, then soared by 108.44% to $1.2 million in 2023, then jumped by 200.49% to $3.7 million in 2024, then soared by 113.17% to $7.9 million in 2025, then soared by 195.6% to $23.3 million in 2026.
- Business Quant data shows PGEN's Revenue at $23.3 million in Q1 2026, $7.9 million in Q4 2025, and $942000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Precigen | 2.18 Bn | 2.18 Bn | 52.17 Mn | 54.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 54.98 Mn |
| Mar 31, 2026 | 23.25 Mn |
| Dec 31, 2025 | 7.87 Mn |
| Sep 30, 2025 | 942,000.00 |
| Jun 30, 2025 | 781,000.00 |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 3.69 Mn |
| Sep 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 717,000.00 |
| Mar 31, 2024 | 1.07 Mn |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1.77 Mn |
| Dec 31, 2022 | -14.55 Mn |
| Sep 30, 2022 | 14.62 Mn |
| Jun 30, 2022 | 2.91 Mn |
| Mar 31, 2022 | 5.51 Mn |
| Dec 31, 2021 | -10.08 Mn |
| Sep 30, 2021 | 3.33 Mn |
| Jun 30, 2021 | 3.82 Mn |